ZYKADIA (Ceritinib) Capsules

What is Zykadia (Ceritinib)
Zykadia is a cancer medication that interferes with the growth and spread of cancer cells in the body. Zykadia is used to treat non-small cell lung cancer caused by a defect in a certain gene.

Zykadia

Drug Manufacturer / Marketeer :

M/s Novartis


Available as:

150MG CAPSULES.

Indications:

  • Zykadia is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK) positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib
  • This indication is approved under accelerated approval based on tumor response rate and duration of response. An improvement in survival or disease related symptoms has not been established.

Treatment:
For treatment related information, please consult your treating Physician.

How supplied:
Zykadia 150 mg is a hard gelatin capsule with opaque blue cap and opaque white body containing a white to off-white powder.
Supplied in a bottle of 70 capsules

Storage and handling:
Store at 20°- 25° C, excursions permitted to 15° to 30° C.

How do we source the Drug?
SMIQ Pharma-India will assist in sourcing the drug through its efficient network,  across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is essential.

Company that Manufactures/ Markets:
M/s Novartis

Assistance Cell in India:
For ONCOLOGY DRUG: ZYKADIA (Ceritinib) Capsules 150MG price.

Contact Mr. TRB Aiyer, Business Associate by call +91 9004695622 or by email  trbaiyer@smiqpharma.comsmiqpharma@gmail.com.